Division of Allergy and Infectious DiseasesUniversity of WashingtonSeattleWAUSA.
Public Health - Seattle King CountySeattleWAUSA.
Hepatol Commun. 2020 Nov 7;5(3):387-399. doi: 10.1002/hep4.1627. eCollection 2021 Mar.
Hepatitis C virus (HCV) infection is common in the United States and leads to significant morbidity, mortality, and economic costs. Simplified screening recommendations and highly effective direct-acting antivirals for HCV present an opportunity to eliminate HCV. The objective of this study was to increase testing, linkage to care, treatment, and cure of HCV. This was an observational, prospective, population-based intervention program carried out between September 2014 and September 2018 and performed in three community health centers, three large multiclinic health care systems, and an HCV patient education and advocacy group in King County, WA. There were 232,214 patients included based on criteria of documented HCV-related diagnosis code, positive HCV laboratory test or prescription of HCV medication, and seen at least once at a participating clinical site in the prior year. Electronic health record (EHR) prompts and reports were created. Case management linked patients to care. Primary care providers received training through classroom didactics, an online curriculum, specialty clinic shadowing, and a telemedicine program. The proportion of baby boomer patients with documentation of HCV testing increased from 18% to 54% during the project period. Of 77,577 baby boomer patients screened at 87 partner clinics, 2,401 (3%) were newly identified HCV antibody positive. The number of patients staged for treatment increased by 391%, and those treated increased by 1,263%. Among the 79% of patients tested after treatment, 95% achieved sustained virologic response. : A combination of EHR-based health care system interventions, active linkage to care, and clinician training contributed to a tripling in the number of patients screened and a more than 10-fold increase of those treated. The interventions are scalable and foundational to the goal of HCV elimination.
丙型肝炎病毒(HCV)感染在美国很常见,导致了大量的发病率、死亡率和经济成本。简化的筛查建议和高效的直接作用抗病毒药物为消除 HCV 提供了机会。本研究的目的是增加 HCV 的检测、与护理的联系、治疗和治愈。这是一项观察性、前瞻性、基于人群的干预计划,于 2014 年 9 月至 2018 年 9 月在三个社区卫生中心、三个大型多诊所医疗保健系统和华盛顿州金县的 HCV 患者教育和倡导组织中进行。根据有记录的 HCV 相关诊断代码、HCV 实验室检测阳性或 HCV 药物处方,以及在前一年至少在一个参与临床地点就诊一次的标准,共纳入 232214 例患者。创建了电子健康记录(EHR)提示和报告。病例管理将患者与护理联系起来。初级保健提供者通过课堂教学、在线课程、专业诊所跟班学习和远程医疗项目接受培训。在项目期间,有 HCV 检测记录的婴儿潮一代患者的比例从 18%增加到 54%。在 87 家合作诊所筛查的 77577 名婴儿潮一代患者中,有 2401 名(3%)新发现 HCV 抗体阳性。接受治疗的患者人数增加了 391%,接受治疗的患者人数增加了 1263%。在接受治疗后接受检测的 79%的患者中,95%的患者达到了持续病毒学应答。:基于电子健康记录的医疗保健系统干预措施、积极的护理联系和临床医生培训相结合,使筛查患者的人数增加了两倍,接受治疗的患者人数增加了 10 多倍。这些干预措施具有可扩展性,是消除 HCV 的基础。